Shari Annes | IR |
Rachel King | CEO |
Brian Hahn | CFO |
Helen Thackray | SVP, Clinical Development and CMO |
Yatin Suneja | SunTrust Robinson Humphrey |
Jotin Marango | Roth Capital |
Stephen Willey | Stifel |
Irina Margine | Cowen |
Good morning, and thank you all for joining the GlycoMimetics' call. At this time all participants are in a listen-only mode. [Operator Instructions] I would now like to turn the call over to Shari Annes of the Investor Relations group at GlycoMimetics. Please, go ahead.
Good morning.